Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the United Kingdom

被引:0
作者
Xie, J. [1 ]
Yong, A. S. M. [2 ]
Waweru, C. [1 ]
Sorof, T. -A. [3 ]
Goyal, R. K. [4 ]
Davis, K. L. [4 ]
Hillmen, P. [5 ]
机构
[1] AstraZeneca LP, Gaithersburg, MD USA
[2] AstraZeneca, Luton, Beds, England
[3] Acerta Pharma, San Francisco, CA USA
[4] RTI Hlth Solut, Res Triangle Pk, NC USA
[5] St James Univ Hosp, Leeds, W Yorkshire, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BSH2020-EP
引用
收藏
页码:221 / 221
页数:1
相关论文
共 50 条
  • [41] Treatment Patterns of Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the Era of Targeted Therapy: A Real-World United States Study
    Yang, Xiaoqin
    Zanardo, Enrico
    Lejeune, Dominique
    De Nigris, Enrico
    Sarpong, Eric
    Farooqui, Mohammed Z. H.
    Donzella, Sidney M.
    Laliberte, Francois
    BLOOD, 2022, 140 : 10932 - 10933
  • [42] Incidence and risk factors of bleedingrelated adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib
    Wiestner, Adrian
    Lipsky, Andrew
    Farooqui, Mohammed
    Tian, Xin
    Cullinane, Ann
    Nghiem, Khanh
    Lozier, Jay
    LEUKEMIA & LYMPHOMA, 2015, 56 : 163 - 164
  • [43] Impact of Real-World Treatment Sequencing Patterns on Time to Next Treatment among Patients with Chronic Lymphocytic Leukemia in the United States
    Chanan-Khan, Asher Alban
    Challagulla, Swetha
    Kaushiva, Alpana
    Miller, Vincent
    Wang, Yuexi
    Smith, Helen
    Yang, Keri
    BLOOD, 2023, 142
  • [44] Real-World Treatment Outcomes in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Were Treated With First-Line Single-Agent Ibrutinib vs Chemoimmunotherapy
    Wang, Ruibin
    Ding, Zhijie
    Lu, Xiaoxiao
    Mavani, Heena
    He, Jinghua
    Qureshi, Zaina
    Pinilla, Javier
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S330 - S330
  • [45] Real-world treatment outcomes in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who were treated with first-line single-agent ibrutinib vs chemoimmunotherapy
    Wang, Ruibin
    Ding, Zhijie
    Lu, Xiaoxiao
    Mavani, Heena
    He, Jinghua
    Qureshi, Zaina
    Pinilla, Javier
    LEUKEMIA & LYMPHOMA, 2023, 64 : S170 - S170
  • [46] Treatment sequencing and outcomes in patients with chronic lymphocytic leukemia: the informCLL™ real-world registry
    Mato, Anthony
    Ghosh, Nilanjan
    Barrientos, Jacqueline
    Brander, Danielle
    Pagel, John
    Gutierrez, Meghan
    Kadish, Karen
    Tomlinson, Brian
    Ipe, David
    Sundaram, Murali
    Han, Jennifer
    Amaya-Chanaga, Carlos
    Iyengar, Reethi
    Sharman, Jeff
    LEUKEMIA & LYMPHOMA, 2020, 61 : 33 - 36
  • [47] Real-World Patterns of MRD Testing and Impact on Treatment for Chronic Lymphocytic Leukemia Patients
    Bacchus, Melissa
    Singh-Bulkan, Nivita
    Littleford, Hana E.
    Kim, Joseph
    Martin, Richard L.
    Lacoste, Alix M. B.
    Brimble, Elise
    O'Brien, Conner
    Saltzman, Larry A.
    Greenberger, Lee M.
    Nottke, Amanda
    BLOOD, 2023, 142
  • [48] Real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States
    Geynisman, Daniel M.
    Broughton, Edward
    Hao, Yi
    Zhang, Ying
    Le, Trong
    Huo, Stephen
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (05) : 195.e1 - 195.e11
  • [49] Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice
    Gribben, John G.
    Bosch, Francesc
    Cymbalista, Florence
    Geisler, Christian H.
    Ghia, Paolo
    Hillmen, Peter
    Moreno, Carol
    Stilgenbauer, Stephan
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (05) : 666 - 679
  • [50] Real-world treatment patterns and health outcomes for patients with myelofibrosis treated with fedratinib
    Passamonti, Francesco
    Korgaonkar, Siddhi
    Parikh, Rohan C.
    Chevli, Manoj
    Yucel, Aylin
    Rombi, Julien
    Jones, Shalon
    Zissler, Dorothy
    Davis, Keith L.
    Slaff, Samantha
    FUTURE ONCOLOGY, 2025, 21 (05) : 579 - 591